ARIBOSAN B31 - LIQ
ARIBOSAN B31 - LIQ
Discontinued
DIN Number
02158876
Drug Class
Human
Market Date
Dec 31, 1996
Company
HC
professional health products
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02158876
AIG Number0827553001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification
ACTIVE INGREDIENTS (8)
APIS MELLIFICAActive
Strength: 3 D / ML
Monograph: APIS MELLIFICA
BARBERRY ROOTActive
Strength: 2 D / ML
Monograph: BARBERRY ROOT
COLCHICINEActive
Strength: 6 D / ML
Monograph: COLCHICINE
CONVALLARIA MAJALISActive
Strength: 3 D / ML
Monograph: CONVALLARIA MAJALIS
NITROGLYCERINActive
Strength: 6 D / ML
Monograph: NITROGLYCERIN
POISON OAKActive
Strength: 4 D / ML
Monograph: POISON OAK
POTASSIUM IODIDEActive
Strength: 1 D / ML
Monograph: POTASSIUM IODIDE
QUININE DIHYDROCHLORIDEActive
Strength: 3 D / ML
Monograph: QUININE DIHYDROCHLORIDE